Mate they would never get the money at 4c now. Institutional investors wont even absorb that amount of risk today.
This is an early stage drug discovery company. Its a handful of years old. Its drug development stage is highly advanced in comparison to the companies lifetime. This isnt 2019 when you just had to mention biotech and money falls from a tree
- Forums
- ASX - By Stock
- CHM
- Ann: Entitlement Offer to raise approximately $10 million
Ann: Entitlement Offer to raise approximately $10 million, page-33
-
- There are more pages in this discussion • 67 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CHM (ASX) to my watchlist
|
|||||
Last
1.9¢ |
Change
0.001(5.56%) |
Mkt cap ! $16.64M |
Open | High | Low | Value | Volume |
1.9¢ | 1.9¢ | 1.9¢ | $3.933K | 207K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 799782 | 1.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.9¢ | 372591 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 799782 | 0.018 |
4 | 957660 | 0.017 |
12 | 3472701 | 0.016 |
10 | 4680065 | 0.015 |
5 | 2331428 | 0.014 |
Price($) | Vol. | No. |
---|---|---|
0.019 | 372591 | 2 |
0.020 | 1114755 | 4 |
0.021 | 488333 | 3 |
0.022 | 350000 | 3 |
0.023 | 155000 | 2 |
Last trade - 10.02am 15/07/2024 (20 minute delay) ? |
Featured News
CHM (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online